» Articles » PMID: 23102782

Effects of Chemokine-like Factor 1 on Vascular Smooth Muscle Cell Migration And proliferation in Vascular Inflammation

Overview
Journal Atherosclerosis
Publisher Elsevier
Date 2012 Oct 30
PMID 23102782
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Vascular smooth muscle cell (VSMC) migration and proliferation are key components of vascular inflammation that may lead to atherosclerosis and restenosis, in which cytokines are considered as pivotal factors regarding recruitment of VSMC. A member of recently described family of chemokines, chemokine-like factor 1 (CKLF1), displays a wide spectrum of chemotaxis. This study investigated the role of CKLF1 in VSMC migration and proliferation during the process of vascular inflammation.

Methods And Results: : The effects of CKLF1 on migration, proliferation and neointimal formation were investigated in cultured VSMCs, rat balloon injured arteries and human atherosclerotic plaques. CKLF1 overexpression greatly enhanced, whereas shRNA knockdown markedly retarded, VSMC migration and proliferation in vitro. In addition, CKLF1 protein accumulated preferentially in neointima of the injured rat arteries in vivo. CKLF1 overexpression resulted in a 2.5-fold increase in intimal thickness. In contrast, shRNA-mediated CKLF1 knockdown significantly suppressed neointima formation by 70% compared that in control group. Intriguingly, besides animal model, higher level of CKLF1 was observed in human atherosclerotic plaques than that in normal arteries.

Conclusion: CKLF1 plays an essential role in migration and proliferation of VSMCs, which in turn facilitated neointimal hyperplasia and atherosclerosis. Inhibition of CKLF1 activity provides a potential target for the prevention of atherosclerosis and restenosis.

Citing Articles

LIM kinases in cardiovascular health and disease.

Lateef O, Foote C, Power G, Manrique-Acevedo C, Padilla J, Martinez-Lemus L Front Physiol. 2025; 15():1506356.

PMID: 39744707 PMC: 11688343. DOI: 10.3389/fphys.2024.1506356.


Utility of serum chemokine-like factor 1 as a biomarker of severity and prognosis after severe traumatic brain injury: A prospective observational study.

Wu X, Su C, Tian D, Ye Y, Du Q, Chen J Brain Behav. 2024; 14(5):e3522.

PMID: 38773776 PMC: 11109498. DOI: 10.1002/brb3.3522.


CKLF1, transcriptionally activated by FOXC1, promotes hypoxia/reoxygenation‑induced oxidative stress and inflammation in H9c2 cells by NLRP3 inflammasome activation.

Jia Y, Pan J Exp Ther Med. 2024; 27(2):59.

PMID: 38234613 PMC: 10790169. DOI: 10.3892/etm.2023.12347.


Delineating the glioblastoma stemness by genes involved in cytoskeletal rearrangements and metabolic alterations.

Kaluzinska-Kolat Z, Kolat D, Kosla K, Pluciennik E, Bednarek A World J Stem Cells. 2023; 15(5):302-322.

PMID: 37342224 PMC: 10277965. DOI: 10.4252/wjsc.v15.i5.302.


Role of chemokine-like factor 1 as an inflammatory marker in diseases.

Li Y, Yu H, Feng J Front Immunol. 2023; 14:1085154.

PMID: 36865551 PMC: 9971601. DOI: 10.3389/fimmu.2023.1085154.